WILMINGTON--31 Oct--PRNewswire/InfoQuest
Company Joins the United Nations Global Compact Initiative
The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts, and chemical solutions, today announced that it has issued its first Corporate Responsibility Commitment (CRC) Report. The report expresses Chemours' corporate responsibility commitment - an extension of the company's growth strategy - as ten ambitious goals targeted for completion by 2030. The goals span eight areas: safety excellence, vibrant communities, empowered employees, climate, water quality, waste, sustainable offerings, and a sustainable supply chain.
As part of this social responsibility initiative Chemours has signed on to the United Nations Global Compact, the world's largest voluntary corporate citizenship and sustainability pact. Chemours is now one of more than 8,000 participating companies that have pledged to operate responsibly and in alignment with universally accepted sustainability principles, to take actions that support the betterment of society, to engage locally where the company has a presence, and to report annually on Chemours' ongoing efforts.
"Chemours is a performance driven company dedicated to making chemistry as responsible as it is essential to everyday life," said Chemours President and CEO Mark Vergnano.
"We are already taking meaningful steps towards achieving our 2030 goals and will report our progress every step of the way. We are fully committed to being a new kind of chemistry company for a world that demands more."
The full CRC report is available to download at chemours.com.
According to Paul Kirsch, president of Chemours' Fluoroproducts business and executive sponsor of this initiative: "Our report is another demonstration that for Chemours, social responsibility is not an option, it's simply the right thing to do. It is who we are and how we operate."
About The Chemours Company
The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry. Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and general industrial manufacturing. Our flagship products include prominent brands such as Teflon(TM), Ti-Pure(TM), Krytox(TM), Viton(TM), Opteon(TM), Freon(TM) and Nafion(TM). Chemours has approximately 7,000 employees and 26 manufacturing sites serving approximately 4,000 customers in North America, Latin America, Asia-Pacific and Europe. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC. For more information please visit chemours.com, or follow us on Twitter @Chemours, or LinkedIn.
About the United Nations Global Compact
The United Nations Global Compact is a call to companies everywhere to align their operations and strategies with ten universally accepted principles in the areas of human rights, labour, environment and anti-corruption, and to take action in support of UN goals and issues embodied in the Sustainable Development Goals. The UN Global Compact is a leadership platform for the development, implementation and disclosure of responsible corporate practices. Launched in 2000, it is the largest corporate sustainability initiative in the world, with more than 9,500 companies and 3,000 non-business signatories based in over 160 countries, and nearly 70 Local Networks. For more information, follow @globalcompact on social media. Join us for the conversation on social media by using hashtag #SDGpioneers.
CONTACT:
NEWS MEDIA
Alvenia Scarborough
Sr. Director of Corporate Communications and Brand Marketing
+1.302.773.4507
media@chemours.com
INVESTORS
Jonathan Lock
VP, Corporate Development and Investor Relations
+1.302.773.2263
investor@chemours.com
No comments:
Post a Comment